HURN

ANALYST NOTE: HURN (Huron Consulting Group Inc.) Date: 2026-06-13 Current Price: $90.56

1. Structural Readiness

State: Forming Aggressive/Pre-Breakout Entry: N/A (Current price is within the consolidation range; entry requires confirmation) Current Price Extension: N/A (Price is currently within the coil structure, not in extension). ATR Context: Current ATR is 6.3% (Very High). This indicates elevated volatility, which is a sizing input for position management but does not alter the structural classification.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Macro Thesis Status: None named at this date. Analysis: As of 2026-06-13, HURN is not being evaluated on a specific secular macro thesis (e.g., "AI Infrastructure Boom" or "Healthcare Reform"). The investment case is strictly tactical, driven by the quality of the technical setup (the forming coil) and the strength of the underlying business fundamentals reported in the most recent earnings cycle. The conviction relies on the alignment of a high-quality business trajectory with a technical structure that has not yet fully resolved to the upside.

3. Business Overview

Company Profile: Huron Consulting Group Inc. is a professional services firm providing expert consulting to clients globally across the United States and international markets. Business Model: The firm operates on a Revenue-Based Revenue (RBR) model, delivering advisory services focused on financial and operational performance, digital transformation, and strategic planning. Revenue is recognized based on the value of services delivered to clients. Industry & Segments:

• Healthcare (50% of 2025 RBR): Serves acute care providers, health systems, payors, and post-acute providers. Focus areas include revenue cycle management, financial advisory, and digital analytics.
• Education (30% of 2025 RBR): Serves public/private colleges, research institutes, and non-profits. Focus includes student lifecycle management and digital tools.
• Commercial (20% of 2025 RBR): Serves life sciences, finance, energy, and industrials. Focus includes cloud technology, restructuring, and capital advisory.

Supporting Evidence (as of 2026-06-13):

• Growth Trajectory: In the first quarter of 2026, RBR grew 12.1% year-over-year to $443.7 million (E10). Bookings for the trailing six months (ending March 31, 2026) were up greater than 20% across all three segments (E2).
• Backlog Strength: Management affirmed that backlog remains at "historically high coverage ratios" across all segments, providing visibility for the remainder of the year (E3).
• Margin Expansion: Adjusted EBITDA as a percentage of RBR increased to 11.4% in Q1 2026, up from 10.5% in Q1 2025 (E9).
• Strategic Acquisitions: The company enhanced its offerings through the June 2025 acquisition of Eclipse Insights (revenue cycle solutions) and 2025 acquisitions of TVG-Treliant and Wilson Perumal (Commercial segment) (E13, E22).
• Guidance: Management affirmed annual RBR guidance of $1.78B–$1.86B, adjusted EBITDA margin of 14.5%–15.0%, and adjusted non-GAAP EPS of $8.35–$9.15 (E4).
• AI Positioning: Management notes a strategy to leverage AI and digital offerings, citing third-party forecasts for double-digit growth in the AI services market (E7, E14).

4. Archetype and Conviction

Archetype: Quality Compounder Rationale: The name fits the "Quality Compounder" archetype due to its consistent execution of margin expansion, strong backlog coverage, and successful integration of accretive acquisitions. The business is not a deep value recovery or a cyclical play; it is a compounder demonstrating organic growth (20%+ bookings growth) and margin inflection (EBITDA margin expansion) simultaneously.

Conviction Stack:

• Thesis Strength: Moderate (Tactical/Setup-led; no external macro tailwind named).
• Evidence Quality: High. The evidence base is robust, with multiple primary sources (earnings transcripts, 10-K/10-Q filings) confirming growth, margin expansion, and guidance affirmation as of May 2026.
• Structural Quality: Moderate to High. The "Forming" coil indicates a healthy consolidation phase. The "Very High" ATR (6.3%) suggests the market is actively pricing in the volatility associated with the breakout, which is typical for high-quality compounders resolving from a base.
• Rerating Potential: High. The combination of double-digit bookings growth, margin expansion, and a backlog at "historically high" levels suggests the market may re-rate the stock once the technical breakout confirms the fundamental strength.

Valuation Context: Forward consensus EPS for FY1 is $8.84 and FY2 is $10.22 (E30). With a current price of $90.56, the stock trades at approximately 10.2x FY1 consensus and 8.9x FY2 consensus. Given the 20%+ bookings growth and margin expansion, this valuation appears reasonable for a quality compounder, though the "Forming" status suggests the market is currently digesting the recent run-up before the next leg.

5. Invalidations, Strengths, and Gaps

What Would Invalidate:

• Fundamental: A significant miss on the affirmed annual RBR guidance ($1.78B–$1.86B) or a contraction in the EBITDA margin below the 14.5% floor.

What Would Strengthen:

• Fundamental: Further confirmation of the "historically high" backlog coverage ratios in subsequent quarters or an acceleration in the 20%+ bookings growth rate.

Gaps in Evidence:

• Breakout Volume: No data is available on the volume profile during the consolidation phase to assess the quality of the accumulation.
• Customer Concentration: While the top 10 clients accounted for 19% of revenue in 2025 (E20), there is no updated data on concentration changes in 2026.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Bookings up >20% across all segments in trailing 6 months; Backlog at historically high coverage ratios; Management affirmed annual RBR and margin guidance; Adjusted EBITDA margin expanded to 11.4% in Q1 2026. Key risks: Technical structure remains "Forming" with no confirmed breakout; Very High ATR (6.3%) indicates elevated volatility and potential for sharp drawdowns if support fails; No named secular thesis to provide external tailwinds. Sizing hint: Position size should reflect the "Forming" status (partial conviction) and the elevated ATR; reduce size relative to a confirmed breakout setup. Expected path: Management expectations for RBR growth and margin expansion should drive the stock to test the upper boundary of the coil; a confirmed breakout would signal the start of the next leg. Expected horizon: 3 to 6 months for the technical structure to resolve into a confirmed breakout or invalidation.